Researchers compared three open source annotation tools, and also looked at correspondence with public databases, identifying a number of stumbling blocks.
The companies will use Personalis' ACE ImmunoID next-generation sequencing platform to analyze tumor samples from clinical trials of Argos' drug.
The company has been working with the VA since 2013, when it it received a contract to provide sequencing and data analysis for enrollees in the Million Veteran Program.
The companies have signed a letter of intent to offer Personalis' next-generation tumor sequencing and interpretation technology to customers in Canada.
The partners will provide comprehensive clinical genomic testing for tumor profiling and inherited genetic disease at LSU Health New Orleans' Precision Medicine Program.
Compared to commercial exome kits and whole-genome sequencing, the firm's test had improved coverage in medically interpretable genes and the 56 ACMG genes.
In April, Butte became director of UCSF's Institute for Computational Health Sciences and executive director of clinical informatics for UC Health Sciences and Services.
N-of-One will provide clinical interpretation services for genomic tests conducted as part of the New England Veterans' Integrated Service Network oncology program
If the regional precision medicine program is successful, the VA might expand it for veterans around the country.
The test, called Neurome, is available from Athena, Quest Diagnostics' genetic testing business for neurological disorders, and is performed by Personalis.
An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.
Research funding in Canada is to remain mostly the same, ScienceInsider reports.
In Science this week: random DNA replication errors play role in cancer, and more.
The Bill and Melinda Gates Foundation embarks on an open-access publishing path.